Ursodeoxycholic acid in chronic hepatitis C

Poupon, Raoul; Serfaly, Lawrence
December 2007
Gut;Dec2007, Vol. 56 Issue 12, p1652
Academic Journal
The article focuses on the randomised study on the effect of the 24-week course of ursodeoxycholic acid in patients with chronic hepatitis C. The authors found out that patients have decreased serum liver enzymes, which was likely associated with its anti-apoptotic effect towards the toxic bile acids. The authors also stressed the importance in understanding the mechanisms of cell death and survival in a pathological setting.


Related Articles

  • Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases. Festi, Davide; Montagnani, Marco; Azzaroli, Francesco; Lodato, Francesca; Mazzella, Giuseppe; Roda, Aldo; Di Biase, Anna Rita; Roda, Enrico; Simoni, Patrizia; Colecchia, Antonio // Current Clinical Pharmacology;May2007, Vol. 2 Issue 2, p155 

    Ursodeoxycholic acid (UDCA), previously used for cholesterol gallstone dissolution, is currently considered the first choice therapy for many forms of cholestatic syndromes. Many mechanisms and sites of action have been proposed for UDCA, but definitive data are still missing regarding the key...

  • Medicinal Treatments of Cholesterol Gallstones: Old, Current and New Perspectives. Portincasa, P.; Di Ciaula, Agostino; Wang, Helen H.; Moschetta, Antonio; Wang, David Q. -H. // Current Medicinal Chemistry;Apr2009, Vol. 16 Issue 12, p1531 

    Cholesterol cholelithiasis is one of the most common and costly digestive diseases. Although gallstones are usually asymptomatic and no treatment is generally required, it is imperative to treat symptomatic gallstones with or without complicated conditions. Laparoscopic cholecystectomy is...

  • Bear Care. Leary, Ingrid // North & South;May2006, Issue 242, p92 

    The article discusses the author's experience when she reported about the condition of a 10-year-old Asiatic bear named Mot Cho which was held captive for five years in Hanoi, Vietnam. The bitter green bile of the bear or ursodeoxycholic acid (UDCA) is being sold as a cure for fever and for its...

  • Bile acids induce arrhythmias: old metabolite, new tricks. Desai, Moreshwar S.; Penny, Daniel J. // Heart;Nov2013, Vol. 99 Issue 22, p1629 

    In this article, the authors focus on the impact of bile acids (BAs) on arrhythmias. They inform that serum levels of hydrophilic bile acid ursodeoxycholic acid (UDCA) are lower in patients with arrhythmias while serum levels of non-UDCA bile acids are higher in them. They also mention that UDCA...

  • The Potential Chemoprotective Effect of Ursodiol. Brand, R.; Thompson, Jon S. // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1687 

    Discusses research being done on the association of ursodiol use with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Reference to a study by B. Y. Tung, M. J. Emond, R. C. Haggit, et al published in a 2001 issue of the "Annals of...

  • Ursocholic Acid, a Hydrophilic Bile Acid, Fails to Improve Liver Function Parameters in Primary Biliary Cirrhosis: Comparison with Ursodeoxycholic Acid. Batta, Ashok K.; Salen, Gerald; Abroon, John // American Journal of Gastroenterology;Jun1997, Vol. 92 Issue 6, p1035 

    Objective: To compare the effect of short term feeding of ursocholic acid, a hydrophilic bile acid, as the unconjugated acid and the taurine conjugate, on clinical and biochemical features and bile acid metabolism with that of ursodeoxycholic acid in four patients with primary biliary cirrhosis....

  • ¿MEJORA EL USO DE ÁCIDO URSODEOXICÓLICO EL PRONÓSTICO PERINATAL EN MUJERES EMBARAZADAS CON COLESTASIA INTRAHEPÁTICA DEL EMBARAZO? Morgan S., Gonzalo; Villalón S., Valentina; Danilla E., Stefan; ViIlavicencio F., Luis; Kottmann G., Cristián; Illanes L., Sebastian // Revista Chilena de Obstetricia y Ginecología;2007, Vol. 72 Issue 5, p292 

    Intrahepatic cholestasis of pregnancy (ICP) is a disease of the third trimester of pregnancy involving pruritus and elevated bile acid levels. Once thought to be benign for both mother and fetus, lCP has been associated with maternal jaundice and increased rates of fetal morbidity and mortality....

  • Ursodeoxycholic Acids: A Safe and Effective Agent for Dissolving Cholesterol Gallstones. Tint, G. Stephen; Salen, Gerald; Colalillo, Anthony; Graber, David; Verga, Diane; Speck, Jeffrey // Annals of Internal Medicine;Sep82, Vol. 97 Issue 3, p351 

    Presents a study which examined the effectiveness of using ursodeoxycholic acid in dissolving cholesterol gallstones and their effect on hepatic bile acid metabolism and liver function. Methods used in the study; Results.

  • Effects of Ursodeoxycholic Acid on Hepatic Inflammation and Histological Stage in Patients with Primary Biliary Cirrhosis. Batts, Kenneth P.; Jorgensen, Roberta A.; Dickson, E. Rolland; Lindor, Keith D. // American Journal of Gastroenterology;Nov1996, Vol. 91 Issue 11, p2314 

    Objectives: Ursodeoxychotic acid (UDCA) has been reported to be of benefit in the treatment of primary biliary cirrhosis; however, the effects of UDCA on the histological features of primary biliary cirrhosis are uncertain. The goat of this study was to determine the histological effects of 2 yr...


Read the Article


Sign out of this library

Other Topics